Comparison of Pre-oxygenation of NIV and HFNC Therapy for Intubation of ICU Patients With Acute Respiratory Failure

NCT ID: NCT02668458

Last Updated: 2017-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

320 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the incidence of severe hypoxemia episodes during the intubation procedure with two methods of pre-oxygenation:

1. NIV (Non Invasive Ventilation)
2. HFNC (High-flow nasal canula oxygen therapy)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Design:

Clinical randomized, open, multicenter, comparative trial, with parallel groups aimed at evaluating a medical device.

Selection of patients admitted to the ICU for acute respiratory failure, requiring endotracheal intubation.

Randomized study, inclusion in two groups: NIV or HFNC.

Experimental group:

NHFC group, preoxygenation by NHFC: oxygen flow rate of 60 L / min and 100% FiO2.

Control group:

NIV group, preoxygenation by NIV: pressure support set for an exhaled tidal volume of 6-8 ml / kg of ideal body weight, PEEP of 5 cm H2O and FiO2 at 100%.

Duration of participation of each patient: 28 days

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Failure Intratracheal Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NIV

NIV group, preoxygenation by NIV: pressure support set for an exhaled tidal volume of 6-8 ml / kg of ideal body weight, PEEP of 5 cm H2O and FiO2 at 100%.

Group Type EXPERIMENTAL

Noninvasive ventilation

Intervention Type PROCEDURE

Pre-oxygenation with non-invasive ventilation

HFNC

High-flow nasal canula oxygen therapy. NHFC group, preoxygenation by NHFC: oxygen flow rate of 60 L / min and 100% FiO2

Group Type ACTIVE_COMPARATOR

High Flow nasal canula oxygen therapy

Intervention Type PROCEDURE

Pre-oxygenation with high-flow nasal canula oxygen therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Flow nasal canula oxygen therapy

Pre-oxygenation with high-flow nasal canula oxygen therapy

Intervention Type PROCEDURE

Noninvasive ventilation

Pre-oxygenation with non-invasive ventilation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* acute hypoxemic respiratory failure requiring endotracheal intubation

Exclusion Criteria

* coma
* NIV contraindication
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poitiers University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Angers

Angers, , France

Site Status

CHU La cavale Blanche

Brest, , France

Site Status

CHU louis MOURIER

Colombes, , France

Site Status

Chu Mondor

Créteil, , France

Site Status

CHU Dijon

Dijon, , France

Site Status

CH Vendée

La Roche/Yon, , France

Site Status

CH La Rochelle

La Rochelle, , France

Site Status

CHU Lille

Lille, , France

Site Status

Limoges University Hospital

Limoges, , France

Site Status

CH St Joseph St Luc

Lyon, , France

Site Status

Chu E. Herriot

Lyon, , France

Site Status

LYON Sud

Lyon, , France

Site Status

CHU marseille

Marseille, , France

Site Status

CH

Montauban, , France

Site Status

CHU Lapeyronie

Montpellier, , France

Site Status

Hopital de l'Archet

Nice, , France

Site Status

CHU La Source

Orléans, , France

Site Status

Chu Cochin

Paris, , France

Site Status

CHU La Pitié Salpétrière

Paris, , France

Site Status

Chu Tenon

Paris, , France

Site Status

CHU Guadeloupe

Pointe à Pitre, , France

Site Status

CHU Poitiers

Poitiers, , France

Site Status

University Hospital of Poitiers

Poitiers, , France

Site Status

Hôpital C. NICOLLE

Rouen, , France

Site Status

CHU Strasbourg

Strasbourg, , France

Site Status

Hôpital FOCH

Suresnes, , France

Site Status

Chu Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Rodriguez M, Ragot S, Coudroy R, Quenot JP, Vignon P, Forel JM, Demoule A, Mira JP, Ricard JD, Nseir S, Colin G, Pons B, Danin PE, Devaquet J, Prat G, Merdji H, Petitpas F, Vivier E, Mekontso-Dessap A, Nay MA, Asfar P, Dellamonica J, Argaud L, Ehrmann S, Fartoukh M, Girault C, Robert R, Thille AW, Frat JP; REVA Network. Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial. Ann Intensive Care. 2021 Jul 22;11(1):114. doi: 10.1186/s13613-021-00892-8.

Reference Type DERIVED
PMID: 34292408 (View on PubMed)

Frat JP, Ricard JD, Quenot JP, Pichon N, Demoule A, Forel JM, Mira JP, Coudroy R, Berquier G, Voisin B, Colin G, Pons B, Danin PE, Devaquet J, Prat G, Clere-Jehl R, Petitpas F, Vivier E, Razazi K, Nay MA, Souday V, Dellamonica J, Argaud L, Ehrmann S, Gibelin A, Girault C, Andreu P, Vignon P, Dangers L, Ragot S, Thille AW; FLORALI-2 study group; REVA network. Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial. Lancet Respir Med. 2019 Apr;7(4):303-312. doi: 10.1016/S2213-2600(19)30048-7. Epub 2019 Mar 18.

Reference Type DERIVED
PMID: 30898520 (View on PubMed)

Frat JP, Ricard JD, Coudroy R, Robert R, Ragot S, Thille AW; on-behalf-of REVA network. Preoxygenation with non-invasive ventilation versus high-flow nasal cannula oxygen therapy for intubation of patients with acute hypoxaemic respiratory failure in ICU: the prospective randomised controlled FLORALI-2 study protocol. BMJ Open. 2017 Dec 22;7(12):e018611. doi: 10.1136/bmjopen-2017-018611.

Reference Type DERIVED
PMID: 29275345 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FLORALI 2

Identifier Type: -

Identifier Source: org_study_id